Table 5 Evaluation of the preliminary outcomes of the program for patients who were diagnosed with prostate cancer within two years, were not employment, and had low household income.

From: Multimedia-based hormone therapy information program for patients with prostate cancer: the result of a randomized pilot study

Outcome

MIG (n = 17)a

CG (n = 15)a

Cohen’s db

Generalized estimating equation

Time

Group × time interaction effects

Mean

SD

Mean

SD

B (SE)

B (SE)

95% CI

Primary outcomes

 Positive thinking

  Pre-test

64.59

6.23

66.00

8.01

− 0.20

   

  8 weeks

66.29

5.93

66.07

8.55

0.03

0.07 (0.99)

1.64 (1.49)

− 1.28, 4.56

  12 weeks

65.65

7.69

65.62

8.60

 < 0.01

1.01 (1.04)

0.05 (1.51)

− 2.91, 3.01

 General QOL

  Pre-test

76.88

13.62

76.27

10.82

0.05

   

  8 weeks

79.47

14.34

73.73

17.92

0.35

− 2.53 (3.49)

5.12 (4.90)

− 4.49, 14.73

  12 weeks

78.18

14.73

74.31

14.63

0.26

− 1.24 (3.07)

2.53 (4.09)

− 5.48, 10.55

 Prostate cancer-specific QOL

  Pre-test

112.76

18.94

110.07

15.90

0.15

   

  8 weeks

117.41

18.10

109.33

22.70

0.39

− 0.73 (4.12)

5.38 (6.00)

− 6.39, 17.15

  12 weeks

116.65

18.99

108.77

20.92

0.39

− 0.30 (4.22)

4.18 (5.31)

− 6.23, 14.59

 Hormone symptoms and distress

  Pre-test

84.63

16.98

85.00

13.95

− 0.02

   

  8 weeks

86.63

14.53

84.55

15.23

0.14

− 0.45 (2.99)

2.46 (4.29)

− 5.95, 10.87

  12 weeks

83.69

14.62

85.14

16.01

− 0.09

− 1.33 (3.47)

0.39 (4.91)

− 9.22, 10.01

Secondary outcomes

 Social support

  Pre-test

34.00

8.60

35.07

6.80

− 0.14

   

  8 weeks

34.76

8.88

34.33

7.47

0.05

− 0.73 (1.04)

1.50 (2.36)

− 3.12, 6.12

  12 weeks

34.71

9.10

33.54

7.16

0.14

− 0.08 (1.73)

0.78 (2.75)

− 4.61, 6.18

 Self-efficacy

  Pre-test

27.65

5.04

29.80

4.55

− 0.45

   

  8 weeks

28.35

3.77

29.27

4.51

− 0.22

− 0.53 (0.80)

1.24 (1.13)

− 0.97, 3.45

  12 weeks

29.65

5.89

28.23

4.00

0.28

− 0.97 (0.96)

2.97 (1.80)

− 0.55, 6.50

  1. Cases included data analysis at pre-test, 8 weeks, and 12 weeks: MIG—17, 17, and 17, respectively, CG—15, 15, and 13, respectively.
  2. aGeneralized estimating equations were employed to assess changes over time, with the pre-test serving as the reference group. All p values > 0.05.
  3. bCohen’s d = (Mean in MIG − Mean in CG)/SDpooled. *p < 0.05, **p < 0.01.
  4. CG control group, CI confidence interval, MIG multimedia information group, QOL quality of life, SD standard deviation, SE standard error.
Back to article page